Molindone Hydrochloride Suppliers & Bulk Manufacturers

Available Forms: Tablets

Available Strengths: 5 mg, 10 mg, 25 mg, 50 mg

Reference Brands: Moban (USA)

Category: Antipsychotropic Drugs

Molindone hydrochloride is a first‑generation (typical) antipsychotic medication used in the management of schizophrenia and related psychotic disorders. It works primarily by blocking dopamine D₂ receptors in the brain to reduce psychotic symptoms. The drug is available as oral tablets in multiple strengths. Historically marketed under the brand Moban, it has been reintroduced in generic form in the U.S. Molindone is known for a distinct side‑effect profile compared with other antipsychotics. Molindone hydrochloride is available in Tablets and strengths such as 5 mg, 10 mg, 25 mg, 50 mg. Sourced from GMP-certified and ISO-compliant manufacturers, this API meets global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical formulation and commercial manufacturing, Molindone hydrochloride is supplied in bulk quantities with complete regulatory support including DMF, COA, and MSDS.

Molindone hydrochloride can be exported to over 30 countries across Asia, Africa, Europe, and Latin America. Flexible packaging, competitive pricing, and a verified supplier network make Pharmatradz a trusted sourcing partner for pharmaceutical companies and contract manufacturers worldwide.

Product Description:

Molindone hydrochloride is a small‑molecule antipsychotic medication classified as a first‑generation (typical) antipsychotic agent. It is primarily indicated for the treatment of schizophrenia, where it helps balance dopamine activity in the brain — a neurotransmitter involved in mood, perception, and thought processes. Molindone works by antagonizing dopamine D₂ receptors, which contributes to the reduction of hallucinations, delusions, and disordered thinking common in psychotic disorders. Originally introduced in the 1970s, molindone was historically marketed under the brand name Moban with tablet strengths ranging from 5 mg up to 100 mg. Although Moban was discontinued at times, generic molindone hydrochloride tablets in strengths such as 5 mg, 10 mg, and 25 mg have been re‑introduced in the U.S. market. Molindone’s side‑effect profile includes common antipsychotic adverse reactions such as drowsiness, dizziness, and extrapyramidal symptoms, with some older literature noting it may cause less weight gain relative to other typical antipsychotics. Due to evolving psychiatric practice, it is used less frequently than newer atypical antipsychotics but remains a recognized therapeutic option in certain clinical contexts.